[1]
|
Falco-Walter, J. (2020) Epilepsy-Definition, Classification, Pathophysiology, and Epidemiology. Seminars in Neurology, 40, 617-623. https://doi.org/10.1055/s-0040-1718719
|
[2]
|
Van Gijn, J. (2011) Localised Convulsions from Tu-mour of the Brain by 1882-1886. Brain: A Journal of Neurology, 10, 2795-2797. https://doi.org/10.1093/brain/awr241
|
[3]
|
Seidel, S., Wehner, T., Miller, D., et al. (2022) Brain Tumor Related Ep-ilepsy: Pathophysiological Approaches and Rational Management of Antiseizure Medication. Neurological Research and Practice, 4, Article No. 45.
https://doi.org/10.1186/s42466-022-00205-9
|
[4]
|
Van Breemen, M.S., Wilms, E.B. and Vecht, C.J. (2007) Epi-lepsy in Patients with Brain Tumours: Epidemiology, Mechanisms, and Management. The Lancet Neurology, 6, 421-430. https://doi.org/10.1016/S1474-4422(07)70103-5
|
[5]
|
Aronica, E., Ciusani, E., Coppola, A., et al. (2023) Epilepsy and Brain Tumors: Two Sides of the Same Coin. Journal of the Neurological Sciences, 446, Article ID: 120584. https://doi.org/10.1016/j.jns.2023.120584
|
[6]
|
Slegers, R.J. and Blumcke, I. (2020) Low-Grade Developmental and Epilepsy Associated Brain Tumors: A Critical Update 2020. Acta Neuropathologica Communications, 8, Article No. 27. https://doi.org/10.1186/s40478-020-00904-x
|
[7]
|
De Groot, M., Reijneveld, J.C., Aronica, E., et al. (2012) Ep-ilepsy in Patients with a Brain Tumour: Focal Epilepsy Requires Focused Treatment. Brain: A Journal of Neurology, 135, 1002-1016. https://doi.org/10.1093/brain/awr310
|
[8]
|
Siegelin, M.D., Schneider, E., Westhoff, M.A., et al. (2021) Current State and Future Perspective of Drug Repurposing in Malignant Glioma. Seminars in Cancer Biology, 68, 92-104. https://doi.org/10.1016/j.semcancer.2019.10.018
|
[9]
|
Stritzelberger, J., Lang, J.D., Mueller, T.M., et al. (2021) Anti-Seizure Medication Is Not Associated with an Increased Risk to Develop Cancer in Epilepsy Patients. Jour-nal of Neurology, 268, 2185-2191.
https://doi.org/10.1007/s00415-020-10379-4
|
[10]
|
Venkataramani, V., Tanev, D.I., Strahle, C., et al. (2019) Glu-tamatergic Synaptic Input to Glioma Cells Drives Brain Tumour Progression. Nature, 573, 532-538. https://doi.org/10.1038/s41586-019-1564-x
|
[11]
|
Venkatesh, H.S., Morishita, W., Geraghty, A.C., et al. (2019) Electrical and Synaptic Integration of Glioma into Neural Circuits. Nature, 573, 539-545. https://doi.org/10.1038/s41586-019-1563-y
|
[12]
|
Lange, F., Weßlau, K., Porath, K., et al. (2019) AMPA Receptor Antagonist Perampanel Affects Glioblastoma Cell Growth and Glutamate Release in Vitro. PLOS ONE, 14, e0211644. https://doi.org/10.1371/journal.pone.0211644
|
[13]
|
Lin, W., Wang, C., Liu, G., et al. (2020) SLC7A11/xCT in Cancer: Biological Functions and Therapeutic Implications. American Journal of Cancer Research, 10, 3106-3126.
|
[14]
|
Polewski, M.D., Reveron-Thornton, R.F., Cherryholmes, G.A., et al. (2017) SLC7A11 Overexpres-sion in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties. Stem Cells and Development, 26, 1236-1246.
https://doi.org/10.1089/scd.2017.0123
|
[15]
|
Polewski, M.D., Reveron-Thornton, R.F., Cherryholmes, G.A., et al. (2016) Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Re-sistance. Molecular Cancer Research: MCR, 14, 1229-1242. https://doi.org/10.1158/1541-7786.MCR-16-0028
|
[16]
|
Yang, X., Liu, J., Wang, C., et al. (2021) miR-18a Pro-motes Glioblastoma Development by Down-Regulating ALOXE3-Mediated Ferroptotic and Anti-Migration Activities. Oncogenesis, 10, Article No. 15.
https://doi.org/10.1038/s41389-021-00304-3
|
[17]
|
Buckingham, S.C., Campbell, S.L., Haas, B.R., et al. (2011) Glutamate Release by Primary Brain Tumors Induces Epileptic Activity. Nature Medicine, 17, 1269-1274. https://doi.org/10.1038/nm.2453
|
[18]
|
Campbell, S.L., Buckingham, S.C. and Sontheimer, H. (2012) Human Glio-ma Cells Induce Hyperexcitability in Cortical Networks. Epilepsia, 53, 1360-1370. https://doi.org/10.1111/j.1528-1167.2012.03557.x
|
[19]
|
Pallud, J., Le Van Quyen, M., Bielle, F., et al. (2014) Cor-tical GABAergic Excitation Contributes to Epileptic Activities around Human Glioma. Science Translational Medicine, 6, 244ra89. https://doi.org/10.1126/scitranslmed.3008065
|
[20]
|
Tewari, B.P., Chaunsali, L., Campbell, S.L., et al. (2018) Perineuronal Nets Decrease Membrane Capacitance of Peritumoral Fast Spiking Interneurons in a Model of Epi-lepsy. Nature Communications, 9, Article No. 4724.
https://doi.org/10.1038/s41467-018-07113-0
|
[21]
|
Koh, H.Y., Kim, S.H., Jang, J., et al. (2018) BRAF Somatic Mutation Contributes to Intrinsic Epileptogenicity in Pediatric Brain Tumors. Nature Medicine, 24, 1662-1668. https://doi.org/10.1038/s41591-018-0172-x
|
[22]
|
Goz, R.U., Akgül, G. and Loturco, J.J. (2020) BRAFV600E Ex-pression in Neural Progenitors Results in a Hyperexcitable Phenotype in Neocortical Pyramidal Neurons. Journal of Neurophysiology, 123, 2449-2464.
https://doi.org/10.1152/jn.00523.2019
|
[23]
|
Yan, H., Parsons, D.W., Jin, G., et al. (2009) IDH1 and IDH2 Muta-tions in Gliomas. The New England Journal of Medicine, 360, 765-773. https://doi.org/10.1056/NEJMoa0808710
|
[24]
|
Mohamed, E., Kumar, A., Zhang, Y., et al. (2022) PI3K/AKT/mTOR Signaling Pathway Activity in IDH-Mutant Diffuse Glioma and Clinical Implications. Neu-ro-Oncology, 24, 1471-1481. https://doi.org/10.1093/neuonc/noac064
|
[25]
|
Neal, A., Kwan, P., O’brien, T.J., et al. (2018) IDH1 and IDH2 Mutations in Postoperative Diffuse Glioma-Associated Epilepsy. Epilepsy & Behavior: E&B, 78, 30-36. https://doi.org/10.1016/j.yebeh.2017.10.027
|
[26]
|
Li, X., Strasser, B., Jafari-Khouzani, K., et al. (2020) Su-per-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-Mutated Human Gliomas. Radiology, 294, 589-597. https://doi.org/10.1148/radiol.2020191529
|
[27]
|
Mortazavi, A., Fayed, I., Bachani, M., et al. (2022) IDH-Mutated Gliomas Promote Epileptogenesis through d-2-Hy- droxyglutarate-Dependent mTOR Hyperactivation. Neuro-Oncology, 24, 1423-1435.
https://doi.org/10.1093/neuonc/noac003
|
[28]
|
Zeng, L.H., Mcdaniel, S., Rensing, N.R., et al. (2010) Regulation of Cell Death and Epileptogenesis by the Mammalian Target of Rapamycin (mTOR): A Double-Edged Sword? Cell Cycle (Georgetown, Tex), 9, 2281-2285.
https://doi.org/10.4161/cc.9.12.11866
|
[29]
|
Yu, K., Lin, C.J., Hatcher, A., et al. (2020) PIK3CA Variants Selec-tively Initiate Brain Hyperactivity during Gliomagenesis. Nature, 578, 166-171. https://doi.org/10.1038/s41586-020-1952-2
|
[30]
|
Prabowo, A.S., Iyer, A.M., Anink, J.J., et al. (2013) Differential Expression of Major Histocompatibility Complex Class I in Developmental Glioneuronal Lesions. Journal of Neuroin-flammation, 10, Article No. 778.
https://doi.org/10.1186/1742-2094-10-12
|
[31]
|
Vezzani, A., Ravizza, T., Bedner, P., et al. (2022) Astrocytes in the Initiation and Progression of Epilepsy. Nature Reviews Neurology, 18, 707-722. https://doi.org/10.1038/s41582-022-00727-5
|
[32]
|
Aronica, E., Ravizza, T., Zurolo, E., et al. (2012) Astrocyte Im-mune Responses in Epilepsy. Glia, 60, 1258-1268.
https://doi.org/10.1002/glia.22312
|
[33]
|
Devinsky, O., Vezzani, A., Najjar, S., et al. (2013) Glia and Epilepsy: Ex-citability and Inflammation. Trends in Neurosciences, 36, 174-184. https://doi.org/10.1016/j.tins.2012.11.008
|
[34]
|
Vezzani, A., Auvin, S., Ravizza, T., et al. (2012) Glia-Neuronal In-teractions in Ictogenesis and Epileptogenesis: Role of Inflammatory Mediators. In: Noebels, J.L., Avoli, M., Rogawski, M.A., et al., Eds., Jasper’s Basic Mechanisms of the Epilepsies, National Center for Biotechnology Information (US), Bethesda.
|
[35]
|
Montgomery, M.K., Kim, S.H., Dovas, A., et al. (2020) Glioma-Induced Alterations in Neuronal Activ-ity and Neurovascular Coupling during Disease Progression. Cell Reports, 31, Article ID: 107500.
https://doi.org/10.1016/j.celrep.2020.03.064
|
[36]
|
Coulter, D.A. and Steinhäuser, C. (2015) Role of Astrocytes in Epilepsy. Cold Spring Harbor Perspectives in Medicine, 5, a022434. https://doi.org/10.1101/cshperspect.a022434
|
[37]
|
De Groot, M., Iyer, A., Zurolo, E., et al. (2012) Overexpression of ADK in Human Astrocytic Tumors and Peritumoral Tissue Is Related to Tumor-Associated Epilepsy. Epilepsia, 53, 58-66.
https://doi.org/10.1111/j.1528-1167.2011.03306.x
|